학술논문

Efficacy and safety of oral roflumilast for moderate-to-severe psoriasis—a randomized controlled trial (PSORRO)
Document Type
Article
Source
In: The Lancet Regional Health - Europe. (The Lancet Regional Health - Europe, July 2023, 30)
Subject
Language
English
ISSN
26667762